Immunotherapy in Bladder Cancer - Alan Bryce

Immunotherapy in Bladder Cancer

E. David Crawford

Alan Bryce, MD is the Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona where he utilizes whole genome sequencing of tumors to identify key driver mutations. His clinical practice centers on genitourinary malignancies (prostate, kidney, bladder, and testicular cancers) and melanoma. Dr. Bryce participates in community outreach to underserved populations and has in interest in health disparities research. He conducts Phase I clinical trials of new cancer drugs.